MEPDPS - 4th Middle East Pharmacoeconomics and Drug Policy Summit 2024
Start:
Fri, 23 Feb 2024, 09:00
End:
Sat, 24 Feb 2024, 17:00
Website:
Venue:
Exhibit
Symposia
Workshops
Organiser
Sponsor
OVERVIEW
As healthcare systems evolve, Pharmacoeconomics will remain a key discipline for guiding decisions that optimize outcomes, resource allocation, and the overall sustainability of healthcare.
This Summit has been meticulously crafted to serve as a dynamic platform for thought leaders, policymakers, and key stakeholders to exchange insights, share experiences, in the areas focused on healthcare policy, the HEOR in healthcare decision making, economic evaluations, VBHC, the implications of HTA, responses to Real-World Evidence, collaboration, affordability, and equity in healthcare, that enhance patient outcomes, ensure accessibility to innovative therapies, and contribute to the sustainability of our healthcare infrastructure.
WHO SHOULD ATTEND
- Regulatory authorities
- Pharmacoeconomists
- Health Economists
- Health Technology Assessment Specialists
- Payers
- Healthcare providers
- Pharma industry
- Pharmacists and more
KEY BENEFITS OF ATTENDING
- Highlight future opportunities and challenges in developing the healthcare and research economy in the GCC countries
- Discuss the novel approaches to value assessment, achieving cost effective healthcare solutions and access to innovative medicines in the GCC
- Understanding the principles of outcome based healthcare and evidence based medication
- Reviewing pharmacoeconomics and outcomes research strategies
- Exploring the real world data, the burden of disease and HTA to make proper assessments and support decision making
Summit Packages
2-Days Summit Access
for Group Registration
Please contact: +971 4 361 9616
Programme Details will be Available Soon
More events
Wed, 16 Oct 2024 - Sat, 19 Oct 2024
Wed, 16 Oct 2024 - Fri, 18 Oct 2024
Thu, 17 Oct 2024 - Sat, 19 Oct 2024
Thu, 17 Oct 2024 - Sun, 20 Oct 2024
Thu, 17 Oct 2024 - Sat, 19 Oct 2024
Thu, 17 Oct 2024 - Sat, 19 Oct 2024